"Bel Borba Aqui" (Abramorama) - Metacritic score: 44; Festivals include: Cinequest 2012
$2,135 in 1 theater:; PSA: $2,135
A Brazilian doc focusing on a local artisic legend in Salvador, this was well placed at the Film Forum, but gained little attraction with its opening.
What it means: Although docs focusing on creative people have had ongoing success recently, this one is falling short so far.
"Wake in Fright" (Drafthouse) - Metacritic score: 86; Festivals include: Cannes 1971, Cannes 2009 (restored), Toronto 2009, AFI 2009
WhenTed Kotcheff's "Outback" - a slightly edited version of "Wake in Fright" - was released by United Artists in 1971 in the US, it drew praise from critics like Pauline Kael for its blunt portrayal of primal masculine at the edge of civilization. Somewhat similar to Sam Peckinpah's "Straw Dogs" a few months later, its in-your-face violence (even in the shorter version) was as offputting to some as it was attention-grabbing. This restored version is being released in theaters, starting with the best showcase for theatrical reissues in the country - NY's Film Forum - and had a respectable gross with minimal advertising.
What it means: Already set in multiple markets over the next weeks, Drafthouse will have one of its top-grossing films so far with this long-unseen cult film.
"Decoding Deepak" (Snag) - Metacritic score: 49; Festivals include: South by Southwest 2012, Hamptons 2012
$9,100 in 3 theaters:; PSA: $3,033
Deepak Chopra's son made this doc about his famous dad, which after a couple of prominent festival showcases opened to mediocre grosses in three cities.
What it means: Chopra's prominence and many fans will keep this going elsewhere, even if theatrical isn't likely to be a major draw.
"The Other Dream Team" (Film Arcade) - Week 2
$12,746 in 7 theaters (+5):; PSA: $1,820; Cumulative: $36,976
After a strong LA opening last week (NY less so), this Olympics basketball doc had mediocre results as it moved into new cities.
What it means: Whatever its future theatrical playoff, any sports doc that gets the attention this has is likely to be a staple on cable and elsewhere later on.
"The Perks of Being a Wallflower" (Lionsgate) - Week 3
$1,525,000 in 221 theaters (+119):; PSA: $6,900; Cumulative: $3,300,000
Barely missing the top 10 for the weekend in the estimates despite playing on only 221 theaters, and competing with the much wider "Pitch Perfect," the PSA only fell a bit over a third despite more than double the theaters, continuing to show the strength the initial limited openings displayed.
What it means: The smart, slow release for this film is paying dividends, with an ulitmate likely much-wider release still ahead. This one is going to be playing for a while.
"Diana Vreeland - The Eye Has to Travel" (IDP) - Week 3
$90,699 in 14 theaters (+11); PSA: $6,479; Cumulative: $194,000
New openings are solid for this fashion-based profile which continues to rise above most other current docs.
What it means: Expect this to continue to grow for the next few weeks as audiences continue to respond.
"How to Survive a Plague" (IFC) - Week 3
$16,100 in 7 theaters (unchanged); PSA: $2,300; Cumulative: $81,700
Mediocre grosses for another well-received social issue doc.
What it means: This is likely to remain a niche doc but one with a long afterlife after theaters.
"Arbitrage" (Roadside Attractions) - Week 4; also available on VOD
$626,465 in 245 (-11) theaters:; PSA: $2,557; Cumulative: $6,039,000
Another terrific hold for this, with the PSA only down about 25%.
What it means: Roadside Attractions' day and date theater and VOD release of "Margin Call" last year was a big deal. Now this film will be the distributors' best-grossing film of the year, easily outgrossing the successful "Friends With Kids" which was theatrical only.
"Liberal Arts" (IFC) - Week 4
$34,800 in 29 (-2) theaters:; PSA: $1,200; Cumulative: $214,000
Very little traction for Josh Radnor's film.
What it means: Not going to get much further.
"Detropia" (LoKi) - Week 5
$30,800 in 11 theaters (unchanged); PSA: $2,800; Cumulative: $220,000Reaching a steady audience and slowly adding to the gross total, this self-distributed doc continues to be an example of what enterprising filmmakers can do without
spending a lot of money.
What it means: LA just came in this week, and other major cities are still to come, so this has room to grow even further.
"Sleepwalk With Me" (IFC) - Week 7; also available on Video on Demand
$110,000 in 100 (-27) theaters:; PSA: $1,000; Cumulative: $2,040,000
Now late in its run, this is one of the longer playing films theatrically with an early VOD availability.
What it means: Theatrical is near the end, but a much longer VOD life is certain.
"Samsara" (Oscilloscope) - Week 7
$116,443 in 54 (-6) theaters:; PSA: $2,239; Cumulative: $1,594,000
A small PSA falloff once again shows the strong word of mouth still working for this documentary even this late in the run.
What it means: This likely will surpass Oscilloscope's "We Need to Talk About Kevin" as their biggest film this year.
"Robot and Frank" (IDP) - Week 8
$67,000 in 72 theaters (-39); PSA: $931; Cumulative: $3,170,000
This successful specialized film is wrapping up its run.
What it means: Expect this to get more attention as Goldwyn pushes for Frank Langella for acting awards.
"Searching for Sugar Man" (Sony Pictures Classics) - Week 11
$89,104 in 38 theaters (+1); PSA: $2,345; Cumulative: $1,438,000
Nowhere close to done yet as a decent and steady PSA means the grosses keep adding up. In a PR coup, subject Rodriguez is being profiled on Sunday's "60 Minutes."
What it means: Almost three months after its opening, the film and its subject keep getting media attention, which could mean even further playoff.
"Intouchables" (Weinstein) - Week 20
$103,000 in 84 (-37) theaters; PSA: $1,226; Cumulative: $12,636,000
Slowing down finally, but hardly through.
What it means: Stunningly, this is the biggest grossing current subtitled film out there despite having opened in May.